Assignee
SANOFI MATURE IP
FR·2 granted patents·2 pending applications·1 citations·filing 2020–2023
Top patents by PatentIndex Score
4 records- 0185US12453712B2Antitumoral use of cabazitaxelSANOFI MATURE IP·Filed 2023·Granted Oct 28, 2025·0 cites·13 claims
- 0282US10716777B2Antitumoral use of cabazitaxelSANOFI MATURE IP·Filed 2020·Granted Jul 21, 2020·1 cites·6 claims
- 0370US2021169843A1Novel antitumoral use of cabazitaxelSANOFI MATURE IP·Filed 2020·Application pending·0 cites
- 0443US2021244704A1Cabazitaxel in mCRPC Patients Previously Treated with Docetaxel and Who Failed a Prior androgen signaling targeted inhibitor AgentSANOFI MATURE IP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SANOFI MATURE IP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →